EEG Hemispheric Asymmetry as a Predictor and Correlate of Short-term Response to Clozapine Treatment in Schizophrenia

Clinical EEG and Neuroscience

Volumn 31, Issue 3, 2000, Pages 145-152

  Knott, V ^a   Labelle, A ^a   Jones, B ^b   Mahoney, C ^a  

^a ROYAL OTTAWA HOSPITAL   (Canada)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Asymmetry; Clozapine; Electroencephalography; Interhemispheric; Intrahemispheric; Schizophrenia

Indexed keywords

CLOZAPINE;

ADULT; AGED; ALPHA RHYTHM; ARTICLE; BETA RHYTHM; CLINICAL ARTICLE; DELTA RHYTHM; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; INTERHEMISPHERIC TRANSFER; MALE; NEGATIVE SYNDROME; NEUROBIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA; THETA RHYTHM;

ADULT; BRAIN MAPPING; CLOZAPINE; DOMINANCE, CEREBRAL; ELECTROENCEPHALOGRAPHY; FEMALE; FOURIER ANALYSIS; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SIGNAL PROCESSING, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 0033912182     PISSN: 15500594     EISSN: None     Source Type: Journal    
DOI: 10.1177/155005940003100308     Document Type: Article

References (70)

1. Shagass C. An electrophysiological view of schizophrenia. Biol Psychiat 1976; 11: 3.
2. Small J. EEG in schizophrenia and affective disorder. In: Hughes JR, Wilson WP,(eds). EEG and Evoked Potentials in Psychiatry and Behavioral Neurology. Boston: Butterworth; 1983: 25-44.
3. Nuwer M. Quantitative EEG: II. Frequency analysis and topographic mapping in clinical settings. J Clin Neurophysiol 1988; 5: 45-85.
4. Prichep L John E. QEEG profiles of psychiatric disorders. Brain Topogr 1992; 4: 249-257.
5. Kennard M. The EEG in schizophrenia. In: Wilson WP,(ed). Applications of Electroencephalography in Psychiatry. Durham NC: Duke University Press; 1965: 168-184.
6. Itil T. Qualitative and quantitative EEG findings in schizophrenia. Schiz Bull 1977; 3: 61-79.
7. Flor-Henry P. Central dynamics, laterality and psychopathology: A commentary. In: Takahashi R, Flor-Henry P, Gruzelier J, Niwa S,(eds). Cerebral Dynamics, Laterality and Psychopathology, Amsterdam: Elsevier; 1987: 3-22.
8. Miyauchi T Tanaka K Hagimoto H Miura T Kishimoto H Matsushita M. Computerized EEG in schizophrenic patients. Biol Psychiat 1990; 28: 488-494.
9. Elbert T Lutzenberger W Rockstroh B Berg P Cohen R. Physical aspects of the EEG in schizophrenics. Biol Psychiat 1992; 32: 595-606.
10. John E Prichep L Alper K, et al. Quantitative electrophysiological characteristics and subtyping of schizophrenia. Biol Psychiat 1994; 36: 801-826.
11. Merrin E Fein G Floyd T Yingling C. EEG asymmetry in schizophrenic patients before and during neuroleptic treatment. Biol Psychiat 1986; 21: 455-464.
12. Buchsbaum M Cappellati J Coppola R Regal F King P van Kammen O. New methods to determine the CNS effects of antigeriatric compounds: EEG topography and glucose use. Drug Div Res 1982; 2: 489-496.
13. Morihisa J Duffy F Wyatt R. Brain electrical activity mapping (BEAM) in schizophrenic patients. Arch Gen Psychiat 1983; 40: 719-728.
14. Morstyn R Duffy F McCarley R. Altered topography of EEG spectral content in schizophrenia. Electroencephalogr Clin Neurophysiol 1983; 56: 263-271.
15. Guenther W Breitling D Banquet J Marcie P Rondot P. EEG mapping of left hemisphere dysfunction during motor performance in schizophrenia. Biol Psychiat 1986; 21: 249-262.
16. Karson C Coppola R. Morisha J, Weinberger D. Computed electroencephalographic activity mapping in schizophrenia. Arch Gen Psychiat 1987; 44: 514-517.
17. Etevenon P Pidoux P Rioux P. Intra- and interhemispheric EEG differences quantified by spectral analysis: Comparative study of two groups of schizophrenics and a control group. Acta Scand 1979; 60: 57-68.
18. Etevenon P. Intra- and inter-hemispheric changes in alpha intensities in EEGs of schizophrenic patients versus matched controls. Biol Psychiat 1984; 19: 247-256.
19. Gaebel W Ulrich G. Topographical distribution of absolute alpha power in the EEG and psychopathology in schizophrenic outpatients. Acta Psychiat Scand 1988; 77: 390-397.
20. Merrin E Floyd T. Negative symptoms and EEG alpha activity in schizophrenic patients. Schiz Res 1992; 8: 11-20.
21. Itil T Marasa J Saletu B Davis S Mucciard A. Computerized EEG: Predictor of outcome in schizophrenia. J Nerv Ment Dis 1975; 160: 188-253.
22. Itil T Shapiro D Schneider S Francis J. Computerized EEG as a predictor of drug response in treatment resistant schizophrenics. J Nerv Ment Dis 1981; 169: 629-637.
23. Czobor P Volavka J. Pretreatment EEG predicts short-term response to haloperidol treatment. Biol Psychiat 1991; 30: 927-942.
24. Small J Milstein V Small I Miller M Kellams J Corsaro C. Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia. Clin Electroencephalogr 1987; 18: 124-136.
25. Goldman-Rakic P Selemon L. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schiz Bull 1997; 23: 437-458.
26. Haber S Fudge J. The interface between dopamine neurons and the amygdala: Implications for schizophrenia. Schiz Bull 1997; 23: 471-482.
27. Braff D Swerdlow N. Neuroanatomy of schizophrenia. Schiz Bull 1977; 23: 509-512.
28. Frith C. Functional brain imaging of the neuropathology of schizophrenia. Schiz Bull 1977; 23: 525-527.
29. Kane J Honeyfeld G Singer J, et al. Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine. Arch Gen Psychiat 1988; 45: 789-796.
30. Czobor P Volavka J. Quantitative electroencephalogram examination of effects of risperidone in schizophrenic patients. J Clin Pharmacopsychiat 1993; 13: 332-342.
31. Kay S Opler L Lindenmayer J. Reliability and validity of the positive and negative syndrome scale in schizophenria. Psychiat Res 1988; 23: 99-110.
32. Kay S Opler L Lindenmayer J. The positive and negative scale (PANSS): Rationale and standardization. Brit J Psychiat 1989; 155: 59-65.
33. John E Prichep P Easton P. Normative data banks and neurometrics: Basic concepts, methods and results of norm constructions. In: Gevins A, Rémond A,(eds). Methods of Analyzing Bioelectric and Magnetic Signals. EEG Handbook of Electroencephalography and Clinical Neurophysiology. Revised Series, Vol 2. New York: Elsevier Science; 1987: 449-495.
34. Fenton G Fenwick P Dollimore J, et al. EEG spectral analysis in schizophrenia. Br J Psychiatry 1980; 136: 445-455.
35. Lacono W. Bilateral electrodermal habituation-dishabituation and resting EEG in remitted schizophrenics. J Nerv Ment Dis 1982; 170: 91-101.
36. Gunther W Breitting D. Predominant sensorimotor area left hemisphere dysfunction in schizophrenia measured by brain electrical activity mapping. Biol Psychiat 1985; 42: 329-334.
37. Matousek M Capone C Okawa M. Measurement of the inter-hemispheral differences as a diagnostic tool in psychiatry. Acta Biol Psychiat 1981; 6: 76-80.
38. Shagass C Roemer R Straumanis J. Relationships between psychiatric diagnosis and some quantitative EEG variables. Arch Gen Psychiat 1983; 39: 1423-1435.
39. Goldstein L. Some relationships between quantified hemispheric EEG and behavioral states in man. In: Gruzelier J, Flor-Henry P,(eds). Hemisphere Asymmetries of Function in Psychopathology. Amsterdam: Elsevier; 1979: 237-254.
40. D'Elia G Jacobson L von Knorring L, et al. Changes in psychopathology in relation to EEG variables and visual averaged evoked responses (VAER) in schizophrenic patients with penfluridol or thiothixene. Acta Psychiat Scand 1977; 55: 309-318.
41. Kemali D Vacca L Marciano F, et al. CEEG findings in schizophrenics, depressives, obsessives, heroin addicts and normals. Adv Biol Psychiat 1981; 6: 17-28.
42. Flor-Henry P. Lateralized temporal-limbic dysfunction and psychopathology. Ann NY Acad Sci 1976; 280: 777-797.
43. Coger R Dymond A Serafetinides E. Electroencephalographic similarities between chronic alcoholics and chronic, nonparanoid schizophrenics. Arch Gen Psychiat 1979; 36: 91-94.
44. Serafetinides E Coger R Martin J, et al. Schizophrenic symptomatology and cerebral dominance patterns: A comparison of EEG, AER, and BPRS measures. Compr Psychiat 1981; 22: 218-225.
45. Reynolds G. Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature 1983; 305: 527-529.
46. Gruzelier J. Functional neuropsychophysiological asymmetry in schizophrenia: A review and reorientation. Schiz Bull 1999; 25: 91-120.
47. Gruzelier J Wilson L Liddiard D Peters E Pusavat L. Cognitive asymmetry patterns in schizophrenia: Active and withdrawn syndromes and sex differences as moderators. Schiz Bull 1999; 25: 349-362.
48. Inguar D Franzen G. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiat Scand 1974; 4: 425-462.
49. Buchsbaum M Enguar D Kessler R, et al. Cerebral glucography with position tomography: Use in normal subjects and in patients with schizophrenia. Arch Gen Psychiat 1982; 39: 251-259.
50. Daniel D Weinberger D Jones D, et al. The effect of amphetamine on regional cerebral flow during cognitive activation in schizophrenia. J Neurosci 1991; 11: 1907-1917.
51. Okubo Y Suhara T Suzuki K, et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 1997; 385: 634-636.
52. Weinberger D, Implications of the normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiat 1987; 44: 660-669.
53. Frith C. Functional brain imaging and the neuropathology of schizophrenia. Schiz Bull 1997; 23: 525-527.
54. Friston K Frith C. Schizophrenia: A disconnection syndrome?. Clin Neurosci 1995; 3: 89-97.
55. Fletcher P Frith C Grasby P Friston K Dolan R. Local and distributed effect of apomorphine on fronto-temporal function in acute unmedicated schizophrenia. J Neurosci 1996; 16: 7055-7062.
56. Manschreck T Redmond D Candela S Maher B. Effects of clozapine on psychiatric symptoms, cognition and functional outcome in schizophrenia. J Neuropsychiat Clin Neurosci 1999; 11: 481-489.
57. Fitton A Heel R. Clozapine: A review of its pharmacological properties and therapeutic use in schizophrenia. Drugs 1990; 40: 722-747.
58. Coward D. General pharmacology of clozapine. Brit J Psychiat 1992; 160 (Suppl 17): 3-11.
59. Freudenreich O Weiner R. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels. Biol Psychiat 1997; 42: 132-137.
60. Gunther W Baqhai T Naber D Spatz R Hippius H. EEG alterations and seizures during treatment with clozapine: A retrospective study of 283 patients. Pharmacopsychiatry 1993; 26: 69-74.
61. Haring C Neudorfer C Schwitzer J, et al. EEG alterations in patients treated with clozapine in relation to plasma levels. Phamacology 1994; 114: 97-100.
62. Malow B Reese K Sato S Bogard P Malhotra A Pickar D. Spectrum of EEG abnormalities during clozapine treatment. Electroencephalogr Clin Neurophysiol 1994; 91: 205-211.
63. Welch J Manschreck T Redmond D. Clozapine-induced seizures and EEG changes. J Neuropsychiat Clin Neurosci 1994; 6: 250-256.
64. Pilley S Stoll A Weiss M, et al. EEG abnormalities before clozapine therapy predict a good clinical response to clozapine. Ann Clin Psychiat 1996; 8: 1-5.
65. Risby E Epstein C Jewart R, et al. Clozaine-induced EEG abnormalities and clinical response to clozapine. J Neuropsychiat Clin Neurosci 1995; 7: 466-470.
66. Treves I Neufeld M. EEG abnormalities in clozapine-treated schizophrenic patients. Europ Neuropsychopharm 1996; 6: 93-94.
67. Denney D Stevens J. Clozapine and seizures. Biol Psychiat 1995; 37: 427-433.
68. Stevens J. Clozapine: The yin and yang of seizures. Biol Psychiat 1995; 37: 425-426.
69. Itil T Itil K. Quantitative EEG brain mapping in psychotropic drug development, drug treatment, and monitoring. Am J Ther 1995; 2: 359-367.
70. Galderisi S Mucci A Bucci P Mignone M Maj M. Multilead quantitative EEG profile of clozapine in resting and vigilance-controlled conditions. Psychiat Res 1996; 67: 113-122.